Free Trial

Cytokinetics (CYTK) SEC Filings & 10K Form

$54.09
-1.84 (-3.29%)
(As of 09/6/2024 ET)

Recent Cytokinetics SEC Filings

DateFilerForm TypeView
09/03/2024
4:06 PM
Cytokinetics (Issuer)
Pletcher Brett A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
4:09 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
4:14 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:00 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
3:07 PM
Cytokinetics (Issuer)
Pletcher Brett A (Reporting)
Form 3/A
08/12/2024
4:31 PM
Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
4:32 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
3:21 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
7:06 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:14 PM
Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/31/2024
3:36 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
3:39 PM
Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2024
3:17 PM
Cytokinetics (Subject)
PARSHALL B LYNNE (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/23/2024
3:47 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
3:21 PM
Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2024
4:05 PM
Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
3:11 PM
Cytokinetics (Subject)
PARSHALL B LYNNE (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/10/2024
4:24 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2024
5:15 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2024
3:06 PM
Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/08/2024
4:06 PM
Cytokinetics (Issuer)
Harrington Robert Arthur (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2024
3:03 PM
Cytokinetics (Subject)
Harrington Robert Arthur (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/03/2024
7:00 PM
Cytokinetics (Issuer)
Harrington Robert Arthur (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
7:02 PM
Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
7:04 PM
Cytokinetics (Issuer)
Kaye Edward M. MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
7:05 PM
Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
7:07 PM
Cytokinetics (Issuer)
Wysenski Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
4:12 PM
Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
4:26 PM
Cytokinetics (Subject)
PARSHALL B LYNNE (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/01/2024
3:43 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/25/2024
7:04 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
3:39 PM
Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
4:13 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
4:17 PM
Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
4:22 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
3:24 PM
Cytokinetics (Subject)
PARSHALL B LYNNE (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/11/2024
4:16 PM
Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/10/2024
4:08 PM
Bhanji Muna (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2024
4:13 PM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
4:23 PM
Cytokinetics (Issuer)
Harrington Robert Arthur (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
9:02 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Say Goodbye to the US Dollar (Ad)

The warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." I believe the American people deserve to control the fate of their own life savings which is why I had my team put together our latest guide to protect your hard-earned wealth before it's too late...

06/04/2024
3:30 PM
Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:36 PM
Cytokinetics (Subject)
PARSHALL B LYNNE (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2024
3:33 PM
Cytokinetics (Issuer)
Wong Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
3:15 PM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2024
4:59 PM
Cytokinetics (Issuer)
Wysenski Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
5:00 PM
Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
5:01 PM
Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
5:03 PM
Cytokinetics (Issuer)
Kaye Edward M. MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
5:04 PM
Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
5:05 PM
Cytokinetics (Issuer)
Harrington Robert Arthur (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
5:06 PM
COSTA SANTO J (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
5:17 PM
Bhanji Muna (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:00 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
6:05 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
3:37 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
4:30 PM
Cytokinetics (Issuer)
Lee Sung (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/25/2024
5:54 PM
Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
3:38 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
3:35 PM
Cytokinetics (Filer)
Form DEF 14A
04/08/2024
3:37 PM
Cytokinetics (Filer)
Form ARS
04/05/2024
6:30 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
5:57 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
6:02 PM
Callos Andrew (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
6:07 PM
Cytokinetics (Issuer)
Wong Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
5:52 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
3:26 PM
Cytokinetics (Issuer)
Wong Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
7:50 AM
Cytokinetics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
02/06/2024
3:43 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
3:38 PM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/02/2024
3:41 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
9:45 AM
Cytokinetics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/22/2024
4:19 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
1:03 PM
BlackRock Inc. (Filed by)
Cytokinetics (Subject)
Form SC 13G/A
01/19/2024
3:49 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/12/2024
4:20 PM
Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2024
3:09 PM
Cytokinetics (Subject)
HENDERSON JOHN T (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/04/2024
3:02 PM
Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/02/2024
4:55 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
3:19 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/27/2023
3:10 PM
Cytokinetics (Subject)
WIERENGA WENDALL (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/27/2023
3:11 PM
Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2023
6:30 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2023
4:22 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2023
3:21 PM
Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/03/2023
4:30 PM
Cytokinetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/30/2023
3:48 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/19/2023
6:32 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2023
4:57 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2023
3:18 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/12/2023
5:39 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Perfect Crypto Buying Opportunity for 50 Cents (Ad)

When cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying with both fists. They know it's only a matter of time before another bull run. Now, Crypto Insiders Are Scooping up Lesser-Known Coins and Making Serious Bank

Go here to get full details on this crypto now.
10/12/2023
3:22 PM
Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/06/2023
3:52 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
3:32 PM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/06/2023
3:09 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2023
3:13 PM
Cytokinetics (Issuer)
Wysenski Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2023
8:06 PM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2023
3:09 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2023
3:18 PM
Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2023
3:09 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:CYTK) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners